tiprankstipranks
Affluent Medical SA (FR:CVX)
:CVX
Want to see FR:CVX full AI Analyst Report?

Affluent Medical SA (CVX) Stock Statistics & Valuation Metrics

2 Followers

Total Valuation

Affluent Medical SA has a market cap or net worth of €183.58M. The enterprise value is €144.00M.
Market Cap€183.58M
Enterprise Value€144.00M

Share Statistics

Affluent Medical SA has 59,243,675 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding59,243,675
Owned by Insiders
Owned by Institutions

Financial Efficiency

Affluent Medical SA’s return on equity (ROE) is -4.50 and return on invested capital (ROIC) is -48.28%.
Return on Equity (ROE)-4.50
Return on Assets (ROA)-0.52
Return on Invested Capital (ROIC)-48.28%
Return on Capital Employed (ROCE)-0.74
Revenue Per Employee0.00
Profits Per Employee0.00
Employee Count66
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Affluent Medical SA is ―. Affluent Medical SA’s PEG ratio is -0.04.
PE Ratio
PS Ratio0.00
PB Ratio12.26
Price to Fair Value12.26
Price to FCF-5.81
Price to Operating Cash Flow-10.50
PEG Ratio-0.04

Income Statement

In the last 12 months, Affluent Medical SA had revenue of 0.00 and earned -24.97M in profits. Earnings per share was -0.63.
Revenue0.00
Gross Profit-2.19M
Operating Income-18.00M
Pretax Income-26.01M
Net Income-24.97M
EBITDA-15.81M
Earnings Per Share (EPS)-0.63

Cash Flow

In the last 12 months, operating cash flow was -11.61M and capital expenditures -116.00K, giving a free cash flow of -11.72M billion.
Operating Cash Flow-11.61M
Free Cash Flow-11.72M
Free Cash Flow per Share-0.20

Dividends & Yields

Affluent Medical SA pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.77
52-Week Price Change119.08%
50-Day Moving Average3.11
200-Day Moving Average2.23
Relative Strength Index (RSI)50.66
Average Volume (3m)9.49K

Important Dates

Affluent Medical SA upcoming earnings date is Sep 24, 2026, During Market Hours (Confirmed).
Last Earnings DateApr 23, 2026
Next Earnings DateSep 24, 2026
Ex-Dividend Date

Financial Position

Affluent Medical SA as a current ratio of 0.30, with Debt / Equity ratio of 433.11%
Current Ratio0.30
Quick Ratio0.30
Debt to Market Cap0.34
Net Debt to EBITDA-1.41
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Affluent Medical SA has paid -1.04M in taxes.
Income Tax-1.04M
Effective Tax Rate0.04

Enterprise Valuation

Affluent Medical SA EV to EBITDA ratio is -5.72, with an EV/FCF ratio of -7.71.
EV to Sales0.00
EV to EBITDA-5.72
EV to Free Cash Flow-7.71
EV to Operating Cash Flow-7.78

Balance Sheet

Affluent Medical SA has €1.76M in cash and marketable securities with €24.04M in debt, giving a net cash position of -€22.28M billion.
Cash & Marketable Securities€1.76M
Total Debt€24.04M
Net Cash-€22.28M
Net Cash Per Share-€0.38
Tangible Book Value Per Share-€0.85

Margins

Gross margin is -373.66%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-373.66%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for Affluent Medical SA is €5.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€5.00
Price Target Upside66.11% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-100.00%
EPS Growth Forecast-50.15%

Scores

Smart ScoreN/A
AI Score